High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.

Source:http://linkedlifedata.com/resource/pubmed/id/21838459

Download in:

View as

General Info

PMID
21838459